Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05775744 · ClinicalTrials.gov registry record · NA
Management of Postpartum Preeclampsia
A NA study of Postpartum Preeclampsia, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 392
- Enrollment target
- 2
- Study locations
NCT05775744: Completed NA study of Postpartum Preeclampsia, sponsored by Rutgers, The State University of New Jersey.
NCT05775744 is a NA study of Postpartum Preeclampsia that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 392 participants, below the 498-participant average among 5 other Postpartum Preeclampsia trials with a reported enrollment target (21% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05775744, a NA study of Postpartum Preeclampsia, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 392 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to assess the effect of a lower treatment threshold for antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.
Primary Outcome
Any patient that returns to the Emergency Department for hypertensive disorders
Conditions Studied
Interventions
- OTHER Tight postpartum blood pressure control
Study Locations (2)
New Jersey
- Cooperman Barnabas Medical Center - Livingston
- Robert Wood Johnson Medical School - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2024-03-26 |
| Phase | NA |
What the finished NCT05775744 record still lists
NCT05775744 is an interventional study that assigns participants to a tested intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 5 other Postpartum Preeclampsia trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Postpartum Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Tight postpartum blood pressure control is the first listed.
NCT05775744 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05775744 about?
NCT05775744 is a clinical study titled "Management of Postpartum Preeclampsia". The aim of this study is to assess the effect of a lower treatment threshold for antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.
What is the current status of trial NCT05775744?
This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2023-03-28. Estimated completion is 2024-03-26.
What conditions does trial NCT05775744 study?
This clinical trial studies the following conditions: Postpartum Preeclampsia.
What interventions are being tested in trial NCT05775744?
The interventions under investigation include: Tight postpartum blood pressure control (OTHER).
Who is sponsoring clinical trial NCT05775744?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05775744 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
RECRUITING · NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
COMPLETED · NA
-
Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia
COMPLETED · NA
-
Postpartum Hypertension Study
RECRUITING · Phase 4
-
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI